UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract PO3-26-01: Preclinical in vitro and in vivo characterization of a novel, wild-type-sparing, PI3Kα H1047R mutant-selective inhibitor

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO3-26-01-PO3-26-01

2024

Volltextzugriff (PDF)

Abstract 1439: In vivo characterization of a selective FGFR2 inhibitor with potency against gatekeeper and molecular brake mutations

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1439-1439

2023

Volltextzugriff (PDF)

Abstract PO3-26-02: Identification of a novel, brain penetrant, EGFR sparing, ErbB2 inhibitor with activity against oncogenic ErbB2 mutations

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO3-26-02-PO3-26-02

2024

Volltextzugriff (PDF)

Abstract 4486: Characterization of a novel mutant selective, EGFR sparing, ErbB2 inhibitor with activity across activating mutations in systemic and CNS tumors

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4486-4486

2024

Volltextzugriff (PDF)

Abstract C161: Identification of a reversible selective FGFR2 clinical development candidate with potency against gatekeeper and molecular brake mutations

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.C161-C161

2023

Volltextzugriff (PDF)

Abstract 167: Pre-clinical characterization of a novel series of FGFR2 selective inhibitors with potency against clinically relevant mutations

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.167-167

2022

Volltextzugriff (PDF)

Abstract 1440: Identification of a novel EGFR sparing brain penetrant ErbB2 inhibitor with activity against oncogenic ErbB2 mutations

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1440-1440

2023

Volltextzugriff (PDF)

Abstract 1473: Nonclinical development of PF-07284890 (ARRY-461), a potent, brain-penetrant, small molecule inhibitor of BRAF V600-mutation-driven tumors in vitro and in vivo

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1473-1473

2021

Volltextzugriff (PDF)

Abstract B267: AR-mTOR-1: A potent, selective mTORC 1/2 kinase inhibitor for the treatment of malignancy

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B267-B267

2009

Volltextzugriff (PDF)

Abstract 4484: AR-mTOR-26 - A potent, selective mTORC 1/2 kinase inhibitor for the treatment of malignancy

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4484-4484

2010

Volltextzugriff (PDF)

Magic Angle Spinning NMR for Reaction Monitoring and Structure Determination of Molecules Attached to Multipin Crowns

Journal of organic chemistry, 1997-02, Vol.62 (3), p.538-539

1997

Volltextzugriff (PDF)

2D SECSY NMR for Combinatorial Chemistry. High-Resolution MAS Spectra for Resin-Bound Molecules

Journal of organic chemistry, 1998-02, Vol.63 (4), p.1309-1311

1998

Volltextzugriff (PDF)

Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010–2016

Clinical infectious diseases, 2019-04, Vol.68 (9), p.1444-1453

2019

Volltextzugriff (PDF)

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor

Journal of medicinal chemistry, 2022-02, Vol.65 (4), p.3123-3133

2022

Volltextzugriff (PDF)

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor

Journal of medicinal chemistry, 2022-02, Vol.65 (4), p.3123-3133

2022

Volltextzugriff (PDF)

Graduate standards for teachers : Final-year preservice teachers potentially identify the gaps

The Australian journal of teacher education, 2016-09, Vol.41 (9), p.135-151

2016

Volltextzugriff (PDF)

Graduate standards for teachers: Final-year preservice teachers potentially identify the gaps

The Australian journal of teacher education, 2016-01, Vol.41 (9), p.135-151

2016

Volltextzugriff (PDF)

Radiation-induced malignant fibrous histiocytoma of the head and neck

Otolaryngology-head and neck surgery, 1998-04, Vol.118 (4), p.529-531

1998

Volltextzugriff (PDF)

Radiation-Induced Malignant Fibrous Histiocytoma of the Head and Neck

Otolaryngology-head and neck surgery, 1998-04, Vol.118 (4), p.529-531

1998

Volltextzugriff (PDF)

Hammer & tongs: a smoking lung anthology

Antigonish Review, 2000 (122), p.57

2000

Volltextzugriff (PDF)

Hammer & tongs: a smoking lung anthology

Antigonish Review, 2000 (121), p.57

2000

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(19)
Reviews
(2)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract PO3-26-01: Preclinical in vitro and in vivo characterization of a novel, wild-type-sparing, PI3Kα H1047R mutant-selective inhibitor

Abstract 1439: In vivo characterization of a selective FGFR2 inhibitor with potency against gatekeeper and molecular brake mutations

Abstract PO3-26-02: Identification of a novel, brain penetrant, EGFR sparing, ErbB2 inhibitor with activity against oncogenic ErbB2 mutations

Abstract 4486: Characterization of a novel mutant selective, EGFR sparing, ErbB2 inhibitor with activity across activating mutations in systemic and CNS tumors

Abstract C161: Identification of a reversible selective FGFR2 clinical development candidate with potency against gatekeeper and molecular brake mutations

Abstract 167: Pre-clinical characterization of a novel series of FGFR2 selective inhibitors with potency against clinically relevant mutations

Abstract 1440: Identification of a novel EGFR sparing brain penetrant ErbB2 inhibitor with activity against oncogenic ErbB2 mutations

Abstract 1473: Nonclinical development of PF-07284890 (ARRY-461), a potent, brain-penetrant, small molecule inhibitor of BRAF V600-mutation-driven tumors in vitro and in vivo

Abstract B267: AR-mTOR-1: A potent, selective mTORC 1/2 kinase inhibitor for the treatment of malignancy

Abstract 4484: AR-mTOR-26 - A potent, selective mTORC 1/2 kinase inhibitor for the treatment of malignancy

Magic Angle Spinning NMR for Reaction Monitoring and Structure Determination of Molecules Attached to Multipin Crowns

2D SECSY NMR for Combinatorial Chemistry. High-Resolution MAS Spectra for Resin-Bound Molecules

Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010–2016

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor

Graduate standards for teachers : Final-year preservice teachers potentially identify the gaps

Graduate standards for teachers: Final-year preservice teachers potentially identify the gaps

Radiation-induced malignant fibrous histiocytoma of the head and neck

Radiation-Induced Malignant Fibrous Histiocytoma of the Head and Neck

Hammer & tongs: a smoking lung anthology

Hammer & tongs: a smoking lung anthology

Suchergebnisse filtern